The rapidly evolving role of cryo-EM in drug design

Since the early 2010s, cryo-electron microscopy (cryo-EM) has evolved to a mainstream structural biology method in what has been dubbed the “resolution revolution”. Pharma companies also began to use cryo-EM in drug discovery, evidenced by a growing number of industry publications. Hitherto limited in resolution, throughput and attainable molecular weight, cryo-EM is rapidly overcoming its main limitations for more widespread use through a new wave of technological advances. This review discusses how cryo-EM has already impacted drug discovery, and how the state-of-the-art is poised to further revolutionize its application to previously intractable proteins as well as new use cases.

[1]  G. Lander,et al.  How low can we go? Structure determination of small biological complexes using single-particle cryo-EM. , 2020, Current opinion in structural biology.

[2]  C. Robinson,et al.  Structure of native lens connexin-46/50 intercellular channels by CryoEM , 2018, Nature.

[3]  M. Vieth,et al.  Structural insights into probe-dependent positive allosterism of the GLP-1 receptor , 2020, Nature Chemical Biology.

[4]  A. Murzin,et al.  Cryo-EM structure of a neuronal functional amyloid implicated in memory persistence in Drosophila , 2020, Science.

[5]  G. Nakamura,et al.  Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab , 2020, Science.

[6]  K. Garcia,et al.  Structure of human Frizzled5 by fiducial-assisted cryo-EM supports a heterodimeric mechanism of canonical Wnt signaling , 2020, eLife.

[7]  Bridget Carragher,et al.  Structure of the Insulin Receptor-Insulin Complex by Single Particle CryoEM analysis , 2018, Nature.

[8]  Diana C. F. Monteiro,et al.  Need for Speed: Examining Protein Behavior during CryoEM Grid Preparation at Different Timescales , 2020, bioRxiv.

[9]  G. Skiniotis,et al.  Development of an antibody fragment that stabilizes GPCR/G-protein complexes , 2018, Nature Communications.

[10]  F. Supek,et al.  Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases , 2020, Journal of medicinal chemistry.

[11]  Margaret S. Landis,et al.  A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor , 2020, bioRxiv.

[12]  W. Yue,et al.  Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism , 2019, Nature Communications.

[13]  B. Delabarre,et al.  An allosteric mechanism for potent inhibition of human ATP-citrate lyase , 2019, Nature.

[14]  S. Iwata,et al.  The discovery of a new antibody for BRIL-fused GPCR structure determination , 2020, Scientific Reports.

[15]  Yi Jiang,et al.  Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir , 2020, Science.

[16]  Mark S. Kindy,et al.  A therapeutic cancer vaccine against GL261 murine glioma , 2016, Journal of Translational Medicine.

[17]  M. G. Belcastro,et al.  Ancient genomes reveal a high diversity of Mycobacterium leprae in medieval Europe , 2018, PLoS pathogens.

[18]  V. Hornak,et al.  Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex , 2019, Nature Chemical Biology.

[19]  T. Ceska,et al.  Cryo-EM in drug discovery. , 2019, Biochemical Society transactions.

[20]  L. Tong,et al.  Cryo-EM as a powerful tool for drug discovery , 2020, Bioorganic & Medicinal Chemistry Letters.

[21]  B. Carragher,et al.  Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application. , 2018, Cell chemical biology.

[22]  M. Schirle,et al.  A small-molecule inhibitor of C5 complement protein , 2019, Nature Chemical Biology.

[23]  Charles Y. Tan,et al.  A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates , 2020, bioRxiv.

[24]  R. Matadeen,et al.  Industrial cryo-EM facility setup and management , 2020, Acta crystallographica. Section D, Structural biology.

[25]  Chenghua Shao,et al.  RCSB Protein Data Bank: Enabling biomedical research and drug discovery , 2019, Protein science : a publication of the Protein Society.

[26]  Cryo-electron microscopy makes waves in pharma labs , 2017, Nature Reviews Drug Discovery.

[27]  Oliver Gassmann,et al.  Changing R&D models in research-based pharmaceutical companies , 2016, Journal of Translational Medicine.

[28]  T. Gonen,et al.  The cryo-EM method microcrystal electron diffraction (MicroED) , 2019, Nature Methods.

[29]  D. Julius,et al.  Structure of the TRPV1 ion channel determined by electron cryo-microscopy , 2013, Nature.

[30]  Katie Kingwell.  Nav1.7 withholds its pain potential , 2019, Nature Reviews Drug Discovery.

[31]  Yong Zi Tan,et al.  Structure and Drug Resistance of the Plasmodium falciparum Transporter PfCRT , 2019, Nature.

[32]  W. Baumeister,et al.  The promise and the challenges of cryo‐electron tomography , 2020, FEBS letters.

[33]  M. Ammirati,et al.  Synthetic antibodies against BRIL as universal fiducial marks for single−particle cryoEM structure determination of membrane proteins , 2020, Nature Communications.

[34]  Hui Xu,et al.  Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin , 2019, Cell.

[35]  Sjors H W Scheres,et al.  Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1 , 2020, IUCrJ.

[36]  M. Agbandje-McKenna,et al.  Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehicles , 2018, PLoS pathogens.

[37]  A. Gavin,et al.  Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymes , 2020, EBioMedicine.

[38]  G. Sprenger,et al.  Mechanism of ribosome shutdown by RsfS in Staphylococcus aureus revealed by integrative structural biology approach , 2020, Nature Communications.

[39]  Radostin Danev,et al.  Routine sub-2.5 Å cryo-EM structure determination of B-family G protein-coupled receptors , 2020, bioRxiv.

[40]  J. Mascola,et al.  SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness , 2020, Nature.

[41]  M. Schapira,et al.  Structure-based view of the druggable genome. , 2020, Drug discovery today.

[42]  Susan S. Taylor,et al.  The In Situ Structure of Parkinson’s Disease-Linked LRRK2 , 2020, Cell.

[43]  Ashwin Chari,et al.  Atomic-resolution protein structure determination by cryo-EM , 2020, Nature.

[44]  Arthur Christopoulos,et al.  Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins. , 2020, ACS pharmacology & translational science.

[45]  Yong Zi Tan,et al.  Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant , 2018, Nature Communications.

[46]  T. S. Kobilka,et al.  Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist , 2020, Proceedings of the National Academy of Sciences.

[47]  Connexin-46/50 in a dynamic lipid environment resolved by CryoEM at 1.9 Å , 2020, Nature communications.

[48]  P. Sexton,et al.  Structure and dynamics of the active Gs-coupled human secretin receptor , 2020, Nature Communications.

[49]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[50]  Arthur Christopoulos,et al.  Dominant Negative G Proteins Enhance Formation and Purification of Agonist-GPCR-G Protein Complexes for Structure Determination. , 2018, ACS pharmacology & translational science.

[51]  Matthias Zwick,et al.  Target 2035: probing the human proteome. , 2019, Drug discovery today.

[52]  Samara L. Reck-Peterson,et al.  Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction , 2020, Nature.

[53]  S. Brohawn,et al.  Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs , 2020, bioRxiv.

[54]  John M. Lindner,et al.  Human Memory B Cells Harbor Diverse Cross‐Neutralizing Antibodies against BK and JC Polyomaviruses , 2019, Immunity.

[55]  H. Stahlberg,et al.  Microfluidic protein isolation and sample preparation for high-resolution cryo-EM , 2019, Proceedings of the National Academy of Sciences.

[56]  R. Welsh,et al.  Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail , 2020, Science.

[57]  Xinchao Yu,et al.  Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex , 2019, PloS one.

[58]  Sjors H. W. Scheres,et al.  An atomic structure of human γ-secretase , 2015, Nature.

[59]  Juan A. Bueren-Calabuig,et al.  Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition , 2019, Proceedings of the National Academy of Sciences.

[60]  P. Sexton,et al.  Activation of the GLP-1 receptor by a non-peptidic agonist , 2020, Nature.

[61]  Gareth J Waldron,et al.  Reducing safety-related drug attrition: the use of in vitro pharmacological profiling , 2012, Nature Reviews Drug Discovery.

[62]  E. Callaway.  ‘It opens up a whole new universe’: Revolutionary microscopy technique sees individual atoms for first time , 2020, Nature.

[63]  C. Langmead,et al.  Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists. , 2020, Molecular cell.

[64]  J. Debreczeni,et al.  Cryo-EM: The Resolution Revolution and Drug Discovery , 2020, SLAS discovery : advancing life sciences R & D.

[65]  David R. Liu,et al.  DNA capture by a CRISPR-Cas9–guided adenine base editor , 2020, Science.

[66]  E. Fischer,et al.  Targeted protein degradation as a powerful research tool in basic biology and drug target discovery , 2020, Nature Structural & Molecular Biology.

[67]  A. Amunts,et al.  Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain , 2019, Science Advances.

[68]  J. Westbrook,et al.  How Structural Biologists and the Protein Data Bank Contributed to Recent FDA New Drug Approvals. , 2019, Structure.

[69]  J. Errey,et al.  Production of membrane proteins in industry: The example of GPCRs. , 2020, Protein expression and purification.

[70]  M. Hartshorn,et al.  Fragment-based drug discovery using cryo-EM. , 2019, Drug discovery today.

[71]  R. Ravelli,et al.  Cryo-EM structures from sub-nl volumes using pin-printing and jet vitrification , 2020, Nature Communications.

[72]  M. Goedert,et al.  Cryo-EM structures of tau filaments. , 2020, Current opinion in structural biology.

[73]  Z. Zhou,et al.  Structural basis of TRPV5 channel inhibition by econazole revealed by cryo-EM , 2017, Nature Structural & Molecular Biology.

[74]  J. Cate,et al.  Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like molecule , 2019, Nature Structural & Molecular Biology.

[75]  S. Scheres,et al.  Single-particle cryo-EM at atomic resolution , 2020, Nature.

[76]  Claudio Ciferri,et al.  Cryo-EM in drug discovery: achievements, limitations and prospects , 2018, Nature Reviews Drug Discovery.

[77]  Erik Franken,et al.  Electron-event representation data enable efficient cryoEM file storage with full preservation of spatial and temporal resolution , 2020, IUCrJ.

[78]  Christopher P. Arthur,et al.  Structure of the secretory immunoglobulin A core , 2020, Science.

[79]  Barney S. Graham,et al.  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.

[80]  Daniel E. Goldberg,et al.  Malaria Parasite Translocon Structure and Mechanism of Effector Export , 2018, Nature.

[81]  M. Ammirati,et al.  Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20 , 2020, Nature Communications.

[82]  M. Congreve,et al.  Impact of GPCR Structures on Drug Discovery , 2020, Cell.

[83]  W. Kühlbrandt.  The Resolution Revolution , 2014, Science.